BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1022292 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(C)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1OC(F)F InChI=1S/C26H36F5N5O5S/c1-6-36-21(17-12-32-19(11-18(17)41-23(27)28)34-24(3,4)13-26(29,30)31)15(2)20(35-36)22(37)33-14-25(38)9-7-16(8-10-25)42(5,39)40/h11-12,16,23,38H,6-10,13-14H2,1-5H3,(H,32,34)(H,33,37)/t16-,25+ YOVGIMCIJPHUJA-NDQYQSCMSA-N 491717 5-(4-(Difluoromethoxy)-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-4-methyl-1H-pyrazole-3-carboxamide::US10975057, Example 1 Nuclear receptor ROR-gamma Human 3.30 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491717&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286150 447118425 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022293 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCC(F)(F)C(F)(F)F)cc1C InChI=1S/C23H29ClF5N5O4S/c1-4-34-19(15-10-30-16(9-13(15)2)31-12-22(25,26)23(27,28)29)17(24)18(33-34)20(35)32-11-21(36)7-5-14(6-8-21)39(3,37)38/h9-10,14,36H,4-8,11-12H2,1-3H3,(H,30,31)(H,32,35)/t14-,21+ SSDSQYKENNTMQQ-QCKZDCLWSA-N 491718 4-Chloro-1-ethyl-5-(4-methyl-6-((2,2,3,3,3-pentafluoropropyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 2 Nuclear receptor ROR-gamma Human 17.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491718&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286157 447118426 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022294 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCC(F)(F)C(F)(F)F)cc1C InChI=1S/C23H29ClF5N5O4S/c1-4-34-19(15-10-30-16(9-13(15)2)31-12-22(25,26)23(27,28)29)17(24)18(33-34)20(35)32-11-21(36)7-5-14(6-8-21)39(3,37)38/h9-10,14,36H,4-8,11-12H2,1-3H3,(H,30,31)(H,32,35)/t14-,21+ SSDSQYKENNTMQQ-QCKZDCLWSA-N 491719 4-Chloro-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-5-(4-methyl-6-((2,2,3,3,3-pentafluoropropyl)amino)pyridin-3-yl)-1H-pyrazole-3-carboxamide::US10975057, Example 3 Nuclear receptor ROR-gamma Human 81.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491719 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491719&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286157 447118427 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022295 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)C(F)(F)F)cc1C InChI=1S/C24H33ClF3N5O4S/c1-6-33-20(16-12-29-17(11-14(16)2)31-22(3,4)24(26,27)28)18(25)19(32-33)21(34)30-13-23(35)9-7-15(8-10-23)38(5,36)37/h11-12,15,35H,6-10,13H2,1-5H3,(H,29,31)(H,30,34)/t15-,23+ ABENSPMUYUAYIU-GUJKFWMDSA-N 491720 4-Chloro-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-5-(4-methyl-6-((1,1,1-trifluoro-2-methylpropan-2-yl)amino)pyridin-3-yl)-1H-pyrazole-3-carboxamide::US10975057, Example 4 Nuclear receptor ROR-gamma Human 20.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491720&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286153 447118428 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022296 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1OC(F)F InChI=1S/C25H33ClF5N5O5S/c1-5-36-20(15-11-32-17(10-16(15)41-22(27)28)34-23(2,3)12-25(29,30)31)18(26)19(35-36)21(37)33-13-24(38)8-6-14(7-9-24)42(4,39)40/h10-11,14,22,38H,5-9,12-13H2,1-4H3,(H,32,34)(H,33,37)/t14-,24+ DBAQUHIRTOTXAB-XCNUYCIISA-N 491721 4-Chloro-5-(4-(difluoromethoxy)-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 5 Nuclear receptor ROR-gamma Human 0.350 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491721 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491721&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286319 447118429 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022297 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](C[C@@H]2O)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1OC(F)F InChI=1S/C25H33ClF5N5O6S/c1-5-36-20(14-10-32-17(9-15(14)42-22(27)28)34-23(2,3)11-25(29,30)31)18(26)19(35-36)21(38)33-12-24(39)7-6-13(8-16(24)37)43(4,40)41/h9-10,13,16,22,37,39H,5-8,11-12H2,1-4H3,(H,32,34)(H,33,38)/t13-,16-,24-/m0/s1 JSWXCXQCFVAIRN-XIKBYKQQSA-N 491722 4-Chloro-5-(4-(difluoromethoxy)-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-N-(((1S*,2S*,4S*)-1,2-dihydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1-ethyl-1H-pyrazole-3-carboxamide::US10975057, Example 6 Nuclear receptor ROR-gamma Human 4.30 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491722 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491722&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286156 447118430 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022298 CCn1nc(C(=O)NC[C@]2(O)CC[C@H](C[C@H]2O)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1OC(F)F InChI=1S/C25H33ClF5N5O6S/c1-5-36-20(14-10-32-17(9-15(14)42-22(27)28)34-23(2,3)11-25(29,30)31)18(26)19(35-36)21(38)33-12-24(39)7-6-13(8-16(24)37)43(4,40)41/h9-10,13,16,22,37,39H,5-8,11-12H2,1-4H3,(H,32,34)(H,33,38)/t13-,16-,24-/m1/s1 JSWXCXQCFVAIRN-VTPJWHAVSA-N 491723 4-Chloro-5-(4-(difluoromethoxy)-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-N-(((1R*,2R*,4R*)-1,2-dihydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1-ethyl-1H-pyrazole-3-carboxamide::US10975057, Example 7 Nuclear receptor ROR-gamma Human 2.50 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491723&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286158 447118431 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022299 CCn1nc(C(=O)NC[C@H]2CC[C@@H](C[C@@H]2O)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1OC(F)F InChI=1S/C25H33ClF5N5O5S/c1-5-36-21(15-11-32-18(9-17(15)41-23(27)28)34-24(2,3)12-25(29,30)31)19(26)20(35-36)22(38)33-10-13-6-7-14(8-16(13)37)42(4,39)40/h9,11,13-14,16,23,37H,5-8,10,12H2,1-4H3,(H,32,34)(H,33,38)/t13-,14+,16+/m1/s1 FRJJOCKYGBFPFZ-YCPHGPKFSA-N 491724 4-Chloro-5-(4-(difluoromethoxy)-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1R*,2S*,4S*)-2-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 8 Nuclear receptor ROR-gamma Human 2.50 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491724&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286277 447118432 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022300 CCn1nc(C(=O)NC[C@@H]2CC[C@H](C[C@H]2O)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1OC(F)F InChI=1S/C25H33ClF5N5O5S/c1-5-36-21(15-11-32-18(9-17(15)41-23(27)28)34-24(2,3)12-25(29,30)31)19(26)20(35-36)22(38)33-10-13-6-7-14(8-16(13)37)42(4,39)40/h9,11,13-14,16,23,37H,5-8,10,12H2,1-4H3,(H,32,34)(H,33,38)/t13-,14+,16+/m0/s1 FRJJOCKYGBFPFZ-SQWLQELKSA-N 491725 4-Chloro-5-(4-(difluoromethoxy)-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1S*,2R*,4R*)-2-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 9 Nuclear receptor ROR-gamma Human 2.50 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491725&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286237 447118433 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022301 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C(F)(F)F)C(F)(F)F)cc1OC(F)F InChI=1S/C23H26ClF8N5O4S/c1-3-37-18(16(24)17(36-37)19(38)34-9-11-4-6-12(7-5-11)42(2,39)40)13-10-33-15(8-14(13)41-21(25)26)35-20(22(27,28)29)23(30,31)32/h8,10-12,20-21H,3-7,9H2,1-2H3,(H,33,35)(H,34,38)/t11-,12- VKCPRIPXMTZRHU-HAQNSBGRSA-N 491726 4-Chloro-5-(4-(difluoromethoxy)-6-((1,1,1,3,3,3-hexafluoropropan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 10 Nuclear receptor ROR-gamma Human 1.000 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491726 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491726&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286231 447118434 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022302 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C(F)(F)F)C(F)(F)F)cc1OC(F)F InChI=1S/C23H26ClF8N5O5S/c1-3-37-17(12-9-33-14(8-13(12)42-20(25)26)35-19(22(27,28)29)23(30,31)32)15(24)16(36-37)18(38)34-10-21(39)6-4-11(5-7-21)43(2,40)41/h8-9,11,19-20,39H,3-7,10H2,1-2H3,(H,33,35)(H,34,38)/t11-,21+ UDFLZGKOIGEVSH-XROVZCQNSA-N 491727 4-Chloro-5-(4-(difluoromethoxy)-6-((1,1,1,3,3,3-hexafluoropropan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 11 Nuclear receptor ROR-gamma Human 5.00 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491727&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286314 447118435 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022303 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(C)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1OC(F)F InChI=1S/C26H36F5N5O4S/c1-6-36-22(15(2)21(35-36)23(37)33-12-16-7-9-17(10-8-16)41(5,38)39)18-13-32-20(11-19(18)40-24(27)28)34-25(3,4)14-26(29,30)31/h11,13,16-17,24H,6-10,12,14H2,1-5H3,(H,32,34)(H,33,37)/t16-,17- MJPCIVWZZVEJGP-QAQDUYKDSA-N 491728 5-(4-(Difluoromethoxy)-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-4-methyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 12 Nuclear receptor ROR-gamma Human 1.10 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491728&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286294 447118436 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022304 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)C(F)(F)C(F)(F)F)cc1OC(F)F InChI=1S/C25H31ClF7N5O5S/c1-5-38-19(17(26)18(37-38)20(39)35-12-23(40)8-6-13(7-9-23)44(4,41)42)14-11-34-16(10-15(14)43-21(27)28)36-22(2,3)24(29,30)25(31,32)33/h10-11,13,21,40H,5-9,12H2,1-4H3,(H,34,36)(H,35,39)/t13-,23+ PXXGABOLUNWKSF-VIUNLEPASA-N 491729 4-Chloro-5-(4-(difluoromethoxy)-6-((3,3,4,4,4-pentafluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 13 Nuclear receptor ROR-gamma Human 5.10 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491729 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491729&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286315 447118437 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022305 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)C(F)(F)C(F)(F)F)cc1OC(F)F InChI=1S/C25H31ClF7N5O4S/c1-5-38-20(18(26)19(37-38)21(39)35-11-13-6-8-14(9-7-13)43(4,40)41)15-12-34-17(10-16(15)42-22(27)28)36-23(2,3)24(29,30)25(31,32)33/h10,12-14,22H,5-9,11H2,1-4H3,(H,34,36)(H,35,39)/t13-,14- DDCFVOJCXBFBAB-HDJSIYSDSA-N 491730 4-Chloro-5-(4-(difluoromethoxy)-6-((3,3,4,4,4-pentafluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 14 Nuclear receptor ROR-gamma Human 1.30 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491730&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286316 447118438 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022306 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1OC(F)F InChI=1S/C25H33ClF5N5O5S/c1-5-36-20(15-11-32-17(10-16(15)41-22(27)28)34-23(2,3)12-25(29,30)31)18(26)19(35-36)21(37)33-13-24(38)8-6-14(7-9-24)42(4,39)40/h10-11,14,22,38H,5-9,12-13H2,1-4H3,(H,32,34)(H,33,37)/t14-,24+ DBAQUHIRTOTXAB-XCNUYCIISA-N 491731 4-Chloro-5-(4-(difluoromethoxy)-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 15 Nuclear receptor ROR-gamma Human 0.920 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491731&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286319 447118439 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022307 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1C(C)C InChI=1S/C27H39ClF3N5O4S/c1-7-36-23(19-13-32-20(12-18(19)16(2)3)34-25(4,5)14-27(29,30)31)21(28)22(35-36)24(37)33-15-26(38)10-8-17(9-11-26)41(6,39)40/h12-13,16-17,38H,7-11,14-15H2,1-6H3,(H,32,34)(H,33,37)/t17-,26+ WVHWASQRVXPOGA-SWGYMIDASA-N 491732 4-Chloro-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-5-(4-isopropyl-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1H-pyrazole-3-carboxamide::US10975057, Example 16 Nuclear receptor ROR-gamma Human 3.80 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491732&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286361 447118440 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022308 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1C(C)C InChI=1S/C27H39ClF3N5O3S/c1-7-36-24(20-14-32-21(12-19(20)16(2)3)34-26(4,5)15-27(29,30)31)22(28)23(35-36)25(37)33-13-17-8-10-18(11-9-17)40(6,38)39/h12,14,16-18H,7-11,13,15H2,1-6H3,(H,32,34)(H,33,37)/t17-,18- FRILVRUKSPWKRP-IYARVYRRSA-N 491733 4-Chloro-1-ethyl-5-(4-isopropyl-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 17 Nuclear receptor ROR-gamma Human 1.90 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491733&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286363 447118441 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022309 CCc1cc(NC(C)(C)CC(F)(F)F)ncc1-c1c(Cl)c(nn1CC)C(=O)NC[C@@]1(O)CC[C@@H](CC1)S(C)(=O)=O InChI=1S/C26H37ClF3N5O4S/c1-6-16-12-19(33-24(3,4)14-26(28,29)30)31-13-18(16)22-20(27)21(34-35(22)7-2)23(36)32-15-25(37)10-8-17(9-11-25)40(5,38)39/h12-13,17,37H,6-11,14-15H2,1-5H3,(H,31,33)(H,32,36)/t17-,25+ KFAODWJIXIAMCZ-CKQQTVSASA-N 491734 4-Chloro-1-ethyl-5-(4-ethyl-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 18 Nuclear receptor ROR-gamma Human 1.20 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491734&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286258 447118442 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022310 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)C(F)(F)F)cc1OC(F)F InChI=1S/C24H31ClF5N5O5S/c1-5-35-19(14-11-31-16(10-15(14)40-21(26)27)33-22(2,3)24(28,29)30)17(25)18(34-35)20(36)32-12-23(37)8-6-13(7-9-23)41(4,38)39/h10-11,13,21,37H,5-9,12H2,1-4H3,(H,31,33)(H,32,36)/t13-,23+ ZIPPRLQAPBOQJK-VIUNLEPASA-N 491735 4-Chloro-5-(4-(difluoromethoxy)-6-((1,1,1-trifluoro-2-methylpropan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 19 Nuclear receptor ROR-gamma Human 6.60 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491735&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286249 447118443 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022311 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)C(F)(F)F)cc1OC(F)F InChI=1S/C24H31ClF5N5O4S/c1-5-35-20(15-12-31-17(10-16(15)39-22(26)27)33-23(2,3)24(28,29)30)18(25)19(34-35)21(36)32-11-13-6-8-14(9-7-13)40(4,37)38/h10,12-14,22H,5-9,11H2,1-4H3,(H,31,33)(H,32,36)/t13-,14- JWFNKCKLTDXMLG-HDJSIYSDSA-N 491736 4-Chloro-5-(4-(difluoromethoxy)-6-((1,1,1-trifluoro-2-methylpropan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 20 Nuclear receptor ROR-gamma Human 2.10 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491736&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286250 447118444 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022312 CC[C@@H](Nc1cc(OC(F)F)c(cn1)-c1c(Cl)c(nn1CC)C(=O)NC[C@H]1CC[C@@H](CC1)S(C)(=O)=O)C(F)(F)F InChI=1S/C24H31ClF5N5O4S/c1-4-17(24(28,29)30)33-18-10-16(39-23(26)27)15(12-31-18)21-19(25)20(34-35(21)5-2)22(36)32-11-13-6-8-14(9-7-13)40(3,37)38/h10,12-14,17,23H,4-9,11H2,1-3H3,(H,31,33)(H,32,36)/t13-,14-,17-/m1/s1 BHPHWUAZORQMDP-CKEIUWERSA-N 491737 4-Chloro-5-(4-(difluoromethoxy)-6-(((R)-1,1,1-trifluorobutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1r,4R)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 21 Nuclear receptor ROR-gamma Human 2.60 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491737&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286251 447118445 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022313 CC[C@@H](Nc1cc(OC(F)F)c(cn1)-c1c(Cl)c(nn1CC)C(=O)NC[C@@]1(O)CC[C@@H](CC1)S(C)(=O)=O)C(F)(F)F InChI=1S/C24H31ClF5N5O5S/c1-4-16(24(28,29)30)33-17-10-15(40-22(26)27)14(11-31-17)20-18(25)19(34-35(20)5-2)21(36)32-12-23(37)8-6-13(7-9-23)41(3,38)39/h10-11,13,16,22,37H,4-9,12H2,1-3H3,(H,31,33)(H,32,36)/t13-,16-,23+/m1/s1 OKBDFMKZTMWUST-SVLHDBBDSA-N 491738 4-Chloro-5-(4-(difluoromethoxy)-6-(((R)-1,1,1-trifluorobutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4S)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 22 Nuclear receptor ROR-gamma Human 13.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491738&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286252 447118446 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022314 CC[C@H](Nc1cc(OC(F)F)c(cn1)-c1c(Cl)c(nn1CC)C(=O)NC[C@H]1CC[C@@H](CC1)S(C)(=O)=O)C(F)(F)F InChI=1S/C24H31ClF5N5O4S/c1-4-17(24(28,29)30)33-18-10-16(39-23(26)27)15(12-31-18)21-19(25)20(34-35(21)5-2)22(36)32-11-13-6-8-14(9-7-13)40(3,37)38/h10,12-14,17,23H,4-9,11H2,1-3H3,(H,31,33)(H,32,36)/t13-,14-,17-/m0/s1 BHPHWUAZORQMDP-ZQIUZPCESA-N 491739 4-Chloro-5-(4-(difluoromethoxy)-6-(((S)-1,1,1-trifluorobutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1r,4S)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 23 Nuclear receptor ROR-gamma Human 4.70 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491739&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286238 447118447 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022315 CC[C@H](Nc1cc(OC(F)F)c(cn1)-c1c(Cl)c(nn1CC)C(=O)NC[C@@]1(O)CC[C@@H](CC1)S(C)(=O)=O)C(F)(F)F InChI=1S/C24H31ClF5N5O5S/c1-4-16(24(28,29)30)33-17-10-15(40-22(26)27)14(11-31-17)20-18(25)19(34-35(20)5-2)21(36)32-12-23(37)8-6-13(7-9-23)41(3,38)39/h10-11,13,16,22,37H,4-9,12H2,1-3H3,(H,31,33)(H,32,36)/t13-,16-,23+/m0/s1 OKBDFMKZTMWUST-AXBCGAQBSA-N 491740 4-Chloro-5-(4-(difluoromethoxy)-6-(((S)-1,1,1-trifluorobutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4R)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 24 Nuclear receptor ROR-gamma Human 19.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491740&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286255 447118448 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022316 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@H](C)C(F)(F)F)cc1OC(F)F InChI=1S/C23H29ClF5N5O4S/c1-4-34-20(15-11-30-17(9-16(15)38-22(25)26)32-12(2)23(27,28)29)18(24)19(33-34)21(35)31-10-13-5-7-14(8-6-13)39(3,36)37/h9,11-14,22H,4-8,10H2,1-3H3,(H,30,32)(H,31,35)/t12-,13-,14-/m1/s1 FFCQHQAYFOJHGS-MGPQQGTHSA-N 491741 4-Chloro-5-(4-(difluoromethoxy)-6-(((R)-1,1,1-trifluoropropan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1r,4R)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 25 Nuclear receptor ROR-gamma Human 5.40 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491741&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286378 447118449 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022317 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@H](C)C(F)(F)F)cc1OC(F)F InChI=1S/C23H29ClF5N5O5S/c1-4-34-19(14-10-30-16(9-15(14)39-21(25)26)32-12(2)23(27,28)29)17(24)18(33-34)20(35)31-11-22(36)7-5-13(6-8-22)40(3,37)38/h9-10,12-13,21,36H,4-8,11H2,1-3H3,(H,30,32)(H,31,35)/t12-,13-,22+/m1/s1 AAYSFQUAGZQFEF-VJBOLBCHSA-N 491742 4-Chloro-5-(4-(difluoromethoxy)-6-(((R)-1,1,1-trifluoropropan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4S)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 26 Nuclear receptor ROR-gamma Human 29.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491742&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286332 447118450 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022318 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)C)cc1OC(F)F InChI=1S/C24H34ClF2N5O5S/c1-6-32-20(15-12-28-17(30-23(2,3)4)11-16(15)37-22(26)27)18(25)19(31-32)21(33)29-13-24(34)9-7-14(8-10-24)38(5,35)36/h11-12,14,22,34H,6-10,13H2,1-5H3,(H,28,30)(H,29,33)/t14-,24+ UGRRLEQHCLLDLT-XCNUYCIISA-N 491743 5-(6-(tert-Butylamino)-4-(difluoromethoxy)pyridin-3-yl)-4-chloro-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 27 Nuclear receptor ROR-gamma Human 11.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491743&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286357 447118451 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022319 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C(C)C)C(F)(F)F)cc1OC(F)F InChI=1S/C25H33ClF5N5O5S/c1-5-36-20(15-11-32-17(10-16(15)41-23(27)28)34-21(13(2)3)25(29,30)31)18(26)19(35-36)22(37)33-12-24(38)8-6-14(7-9-24)42(4,39)40/h10-11,13-14,21,23,38H,5-9,12H2,1-4H3,(H,32,34)(H,33,37)/t14-,21?,24+ YZVTUBQSJXYKAF-RNOOQKDHSA-N 491744 4-Chloro-5-(4-(difluoromethoxy)-6-((1,1,1-trifluoro-3-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 28 Nuclear receptor ROR-gamma Human 4.20 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491744&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286313 447118452 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022320 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@H](C(C)C)C(F)(F)F)cc1OC(F)F InChI=1S/C25H33ClF5N5O5S/c1-5-36-20(15-11-32-17(10-16(15)41-23(27)28)34-21(13(2)3)25(29,30)31)18(26)19(35-36)22(37)33-12-24(38)8-6-14(7-9-24)42(4,39)40/h10-11,13-14,21,23,38H,5-9,12H2,1-4H3,(H,32,34)(H,33,37)/t14-,21-,24+/m1/s1 YZVTUBQSJXYKAF-CGOGNOBXSA-N 491745 4-Chloro-5-(4-(difluoromethoxy)-6-(((R*)-1,1,1-trifluoro-3-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4S)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 29 Nuclear receptor ROR-gamma Human 3.10 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491745&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 149462885 447118453 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022321 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@@H](C(C)C)C(F)(F)F)cc1OC(F)F InChI=1S/C25H33ClF5N5O5S/c1-5-36-20(15-11-32-17(10-16(15)41-23(27)28)34-21(13(2)3)25(29,30)31)18(26)19(35-36)22(37)33-12-24(38)8-6-14(7-9-24)42(4,39)40/h10-11,13-14,21,23,38H,5-9,12H2,1-4H3,(H,32,34)(H,33,37)/t14-,21-,24+/m0/s1 YZVTUBQSJXYKAF-KLGSUFROSA-N 491746 4-Chloro-5-(4-(difluoromethoxy)-6-(((S*)-1,1,1-trifluoro-3-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4R)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 30 Nuclear receptor ROR-gamma Human 5.90 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491746&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286375 447118454 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022322 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCC(C)(C)C)cc1OC(F)F InChI=1S/C25H36ClF2N5O5S/c1-6-33-21(16-12-29-18(30-13-24(2,3)4)11-17(16)38-23(27)28)19(26)20(32-33)22(34)31-14-25(35)9-7-15(8-10-25)39(5,36)37/h11-12,15,23,35H,6-10,13-14H2,1-5H3,(H,29,30)(H,31,34)/t15-,25+ HHYJHFJJUKBHQI-AHPHSXTOSA-N 491747 4-Chloro-5-(4-(difluoromethoxy)-6-(neopentylamino)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 31 Nuclear receptor ROR-gamma Human 11.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491747&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286334 447118455 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022323 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1C(C)(F)F InChI=1S/C26H35ClF5N5O3S/c1-6-37-22(17-13-33-19(11-18(17)25(4,28)29)35-24(2,3)14-26(30,31)32)20(27)21(36-37)23(38)34-12-15-7-9-16(10-8-15)41(5,39)40/h11,13,15-16H,6-10,12,14H2,1-5H3,(H,33,35)(H,34,38)/t15-,16- PKLGILPJMHIRAG-WKILWMFISA-N 491748 4-Chloro-5-(4-(1,1-difluoroethyl)-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 32 Nuclear receptor ROR-gamma Human 0.650 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491748&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286326 447118456 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022324 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1C(C)(F)F InChI=1S/C26H35ClF5N5O4S/c1-6-37-21(16-12-33-18(11-17(16)24(4,28)29)35-23(2,3)13-26(30,31)32)19(27)20(36-37)22(38)34-14-25(39)9-7-15(8-10-25)42(5,40)41/h11-12,15,39H,6-10,13-14H2,1-5H3,(H,33,35)(H,34,38)/t15-,25+ PIWLACKOZWCPOM-AHPHSXTOSA-N 491749 4-Chloro-5-(4-(1,1-difluoroethyl)-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 33 Nuclear receptor ROR-gamma Human 0.780 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491749&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286247 447118457 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022325 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCCCC(F)(F)F)cc1OC InChI=1S/C24H33ClF3N5O4S/c1-4-33-22(17-14-30-19(12-18(17)37-2)29-11-5-10-24(26,27)28)20(25)21(32-33)23(34)31-13-15-6-8-16(9-7-15)38(3,35)36/h12,14-16H,4-11,13H2,1-3H3,(H,29,30)(H,31,34)/t15-,16- NHZLLKKDEPFKQI-WKILWMFISA-N 491750 4-Chloro-1-ethyl-5-(4-methoxy-6-((4,4,4-trifluorobutyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 34 Nuclear receptor ROR-gamma Human 71.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491750&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286256 447118458 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022326 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCCOCC(F)(F)F)cc1OC InChI=1S/C24H33ClF3N5O5S/c1-4-33-22(17-13-30-19(11-18(17)37-2)29-9-10-38-14-24(26,27)28)20(25)21(32-33)23(34)31-12-15-5-7-16(8-6-15)39(3,35)36/h11,13,15-16H,4-10,12,14H2,1-3H3,(H,29,30)(H,31,34)/t15-,16- AYZUTHOEFPOVIZ-WKILWMFISA-N 491751 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(2,2,2-trifluoroethoxy)ethyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 35 Nuclear receptor ROR-gamma Human 250 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491751&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286232 447118459 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022327 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCCCOCC(F)(F)F)cc1OC InChI=1S/C25H35ClF3N5O5S/c1-4-34-23(18-14-31-20(12-19(18)38-2)30-10-5-11-39-15-25(27,28)29)21(26)22(33-34)24(35)32-13-16-6-8-17(9-7-16)40(3,36)37/h12,14,16-17H,4-11,13,15H2,1-3H3,(H,30,31)(H,32,35)/t16-,17- FXTSAISWSORVIG-QAQDUYKDSA-N 491752 4-Chloro-1-ethyl-5-(4-methoxy-6-((3-(2,2,2-trifluoroethoxy)propyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 36 Nuclear receptor ROR-gamma Human 690 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491752&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286248 447118460 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022328 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCCSC(F)(F)F)cc1OC InChI=1S/C23H31ClF3N5O4S2/c1-4-32-21(16-13-29-18(11-17(16)36-2)28-9-10-37-23(25,26)27)19(24)20(31-32)22(33)30-12-14-5-7-15(8-6-14)38(3,34)35/h11,13-15H,4-10,12H2,1-3H3,(H,28,29)(H,30,33)/t14-,15- XJHAYOQGOJQWTF-SHTZXODSSA-N 491753 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-((trifluoromethyl)thio)ethyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 37 Nuclear receptor ROR-gamma Human 30.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491753&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286254 447118461 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022329 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCC2CC[C@@H](CC2)C(F)(F)F)cc1OC InChI=1S/C28H39ClF3N5O4S/c1-4-37-26(24(29)25(36-37)27(38)35-15-18-7-11-20(12-8-18)42(3,39)40)21-16-34-23(13-22(21)41-2)33-14-17-5-9-19(10-6-17)28(30,31)32/h13,16-20H,4-12,14-15H2,1-3H3,(H,33,34)(H,35,38)/t17?,18-,19-,20- NIRSYSNKEZAJEZ-SNYBBNQQSA-N 491754 4-Chloro-1-ethyl-5-(4-methoxy-6-((((1s*,4s*)-4-(trifluoromethyl)cyclohexyl)methyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 38 Nuclear receptor ROR-gamma Human 19.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491754&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286235 447118462 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022330 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCC2CC[C@@H](CC2)C(F)(F)F)cc1OC InChI=1S/C28H39ClF3N5O4S/c1-4-37-26(24(29)25(36-37)27(38)35-15-18-7-11-20(12-8-18)42(3,39)40)21-16-34-23(13-22(21)41-2)33-14-17-5-9-19(10-6-17)28(30,31)32/h13,16-20H,4-12,14-15H2,1-3H3,(H,33,34)(H,35,38)/t17?,18-,19-,20- NIRSYSNKEZAJEZ-SNYBBNQQSA-N 491755 4-Chloro-1-ethyl-5-(4-methoxy-6-((((1r*,4r*)-4-(trifluoromethyl)cyclohexyl)methyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 39 Nuclear receptor ROR-gamma Human 46.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491755&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286235 447118463 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022331 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@@H](C)C2CC2)cc1OC InChI=1S/C25H36ClN5O4S/c1-5-31-24(19-14-27-21(12-20(19)35-3)29-15(2)17-8-9-17)22(26)23(30-31)25(32)28-13-16-6-10-18(11-7-16)36(4,33)34/h12,14-18H,5-11,13H2,1-4H3,(H,27,29)(H,28,32)/t15-,16-,18-/m0/s1 NQZJORIYRXRSDA-BQFCYCMXSA-N 491756 4-Chloro-5-(6-(((S)-1-cyclopropylethyl)amino)-4-methoxypyridin-3-yl)-1-ethyl-N-(((1r,4S)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 40 Nuclear receptor ROR-gamma Human 63.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491756&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286257 447118464 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022332 CCn1nc(C(=O)NC[C@H]2CC[C@H](C)CC2)c(Cl)c1-c1cnc(N[C@@H]2CCCCC2(F)F)cc1OC InChI=1S/C26H36ClF2N5O2/c1-4-34-24(22(27)23(33-34)25(35)31-14-17-10-8-16(2)9-11-17)18-15-30-21(13-19(18)36-3)32-20-7-5-6-12-26(20,28)29/h13,15-17,20H,4-12,14H2,1-3H3,(H,30,32)(H,31,35)/t16-,17-,20-/m1/s1 VJYMZOVJRKKFHD-MBOZVWFJSA-N 491757 4-Chloro-5-(6-(((R*)-2,2-difluorocyclohexyl)amino)-4-methoxypyridin-3-yl)-1-ethyl-N-(((1r,4R)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 41 Nuclear receptor ROR-gamma Human 23.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491757&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 153296607 447118465 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022333 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@H]2CCCCC2(F)F)cc1OC InChI=1S/C26H36ClF2N5O4S/c1-4-34-24(18-15-30-21(13-19(18)38-2)32-20-7-5-6-12-26(20,28)29)22(27)23(33-34)25(35)31-14-16-8-10-17(11-9-16)39(3,36)37/h13,15-17,20H,4-12,14H2,1-3H3,(H,30,32)(H,31,35)/t16-,17-,20-/m0/s1 IEBUEGNYKJJVCT-ZWOKBUDYSA-N 491758 4-Chloro-5-(6-(((S*)-2,2-difluorocyclohexyl)amino)-4-methoxypyridin-3-yl)-1-ethyl-N-(((1r,4S)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 42 Nuclear receptor ROR-gamma Human 16.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491758&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 147900017 447118466 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022334 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(C)c1-c1cnc(NCCOCC(F)(F)F)cc1OC InChI=1S/C25H36F3N5O5S/c1-5-33-23(19-14-30-21(12-20(19)37-3)29-10-11-38-15-25(26,27)28)16(2)22(32-33)24(34)31-13-17-6-8-18(9-7-17)39(4,35)36/h12,14,17-18H,5-11,13,15H2,1-4H3,(H,29,30)(H,31,34)/t17-,18- SIWNMWVRFZEGNZ-IYARVYRRSA-N 491759 1-Ethyl-5-(4-methoxy-6-((2-(2,2,2-trifluoroethoxy)ethyl)amino)pyridin-3-yl)-4-methyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 43 Nuclear receptor ROR-gamma Human 720 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491759&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286197 447118467 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022335 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(C)c1-c1cnc(NCCCOCC(F)(F)F)cc1OC InChI=1S/C26H38F3N5O5S/c1-5-34-24(20-15-31-22(13-21(20)38-3)30-11-6-12-39-16-26(27,28)29)17(2)23(33-34)25(35)32-14-18-7-9-19(10-8-18)40(4,36)37/h13,15,18-19H,5-12,14,16H2,1-4H3,(H,30,31)(H,32,35)/t18-,19- GITBBKUUJJHZLK-WGSAOQKQSA-N 491760 1-Ethyl-5-(4-methoxy-6-((3-(2,2,2-trifluoroethoxy)propyl)amino)pyridin-3-yl)-4-methyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 44 Nuclear receptor ROR-gamma Human 2000 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491760&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286193 447118468 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022336 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(C)c1-c1cnc(NCCSC(F)(F)F)cc1OC InChI=1S/C24H34F3N5O4S2/c1-5-32-22(18-14-29-20(12-19(18)36-3)28-10-11-37-24(25,26)27)15(2)21(31-32)23(33)30-13-16-6-8-17(9-7-16)38(4,34)35/h12,14,16-17H,5-11,13H2,1-4H3,(H,28,29)(H,30,33)/t16-,17- HSLSQOGNRGZVGB-QAQDUYKDSA-N 491761 1-Ethyl-5-(4-methoxy-6-((2-((trifluoromethyl)thio)ethyl)amino)pyridin-3-yl)-4-methyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 45 Nuclear receptor ROR-gamma Human 71.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491761&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286362 447118469 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022337 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(C)c1-c1cnc(NCC2CC[C@@H](CC2)C(F)(F)F)cc1OC InChI=1S/C29H42F3N5O4S/c1-5-37-27(18(2)26(36-37)28(38)35-16-20-8-12-22(13-9-20)42(4,39)40)23-17-34-25(14-24(23)41-3)33-15-19-6-10-21(11-7-19)29(30,31)32/h14,17,19-22H,5-13,15-16H2,1-4H3,(H,33,34)(H,35,38)/t19?,20-,21-,22- WVWHHHPMCROTGZ-PROGVTPTSA-N 491762 1-Ethyl-5-(4-methoxy-6-((((1s*,4s*)-4-(trifluoromethyl)cyclohexyl)methyl)amino)pyridin-3-yl)-4-methyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 46 Nuclear receptor ROR-gamma Human 47.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491762&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286194 447118470 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022338 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(C)c1-c1cnc(NCC2CC[C@@H](CC2)C(F)(F)F)cc1OC InChI=1S/C29H42F3N5O4S/c1-5-37-27(18(2)26(36-37)28(38)35-16-20-8-12-22(13-9-20)42(4,39)40)23-17-34-25(14-24(23)41-3)33-15-19-6-10-21(11-7-19)29(30,31)32/h14,17,19-22H,5-13,15-16H2,1-4H3,(H,33,34)(H,35,38)/t19?,20-,21-,22- WVWHHHPMCROTGZ-PROGVTPTSA-N 491763 1-Ethyl-5-(4-methoxy-6-((((1r*,4r*)-4-(trifluoromethyl)cyclohexyl)methyl)amino)pyridin-3-yl)-4-methyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 47 Nuclear receptor ROR-gamma Human 110 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491763&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286194 447118471 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022339 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(C)c1-c1cnc(N[C@@H](C)C2CC2)cc1OC InChI=1S/C26H39N5O4S/c1-6-31-25(21-15-27-23(13-22(21)35-4)29-17(3)19-9-10-19)16(2)24(30-31)26(32)28-14-18-7-11-20(12-8-18)36(5,33)34/h13,15,17-20H,6-12,14H2,1-5H3,(H,27,29)(H,28,32)/t17-,18-,20-/m0/s1 ZCCPQROIOPXDKI-BJLQDIEVSA-N 491764 5-(6-(((S)-1-Cyclopropylethyl)amino)-4-methoxypyridin-3-yl)-1-ethyl-4-methyl-N-(((1r,4S)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 48 Nuclear receptor ROR-gamma Human 170 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491764&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286196 447118472 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022340 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1OC InChI=1S/C25H35ClF3N5O4S/c1-6-34-22(17-13-30-19(11-18(17)38-4)32-24(2,3)14-25(27,28)29)20(26)21(33-34)23(35)31-12-15-7-9-16(10-8-15)39(5,36)37/h11,13,15-16H,6-10,12,14H2,1-5H3,(H,30,32)(H,31,35)/t15-,16- LQXNGPZCHXEYAB-WKILWMFISA-N 491765 4-Chloro-1-ethyl-5-(4-methoxy-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 49 Nuclear receptor ROR-gamma Human 0.410 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491765&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286291 447118473 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022341 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(cc1OC)N1CC(F)(F)C1 InChI=1S/C23H30ClF2N5O4S/c1-4-31-21(16-11-27-18(9-17(16)35-2)30-12-23(25,26)13-30)19(24)20(29-31)22(32)28-10-14-5-7-15(8-6-14)36(3,33)34/h9,11,14-15H,4-8,10,12-13H2,1-3H3,(H,28,32)/t14-,15- NCGFYRXGGLAGGE-SHTZXODSSA-N 491766 4-Chloro-5-(6-(3,3-difluoroazetidin-1-yl)-4-methoxypyridin-3-yl)-1-ethyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 50 Nuclear receptor ROR-gamma Human 620 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491766&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286303 447118474 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022342 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(cc1OC)N1CC(CC(F)(F)F)C1 InChI=1S/C25H33ClF3N5O4S/c1-4-34-23(18-12-30-20(9-19(18)38-2)33-13-16(14-33)10-25(27,28)29)21(26)22(32-34)24(35)31-11-15-5-7-17(8-6-15)39(3,36)37/h9,12,15-17H,4-8,10-11,13-14H2,1-3H3,(H,31,35)/t15-,17- JVHTUFYUHQIANO-JCNLHEQBSA-N 491767 4-Chloro-1-ethyl-5-(4-methoxy-6-(3-(2,2,2-trifluoroethyl)azetidin-1-yl)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 51 Nuclear receptor ROR-gamma Human 3300 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491767&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286301 447118475 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022343 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2CC(F)(F)C2)cc1OC InChI=1S/C24H32ClF2N5O4S/c1-4-32-22(17-13-28-19(9-18(17)36-2)30-15-10-24(26,27)11-15)20(25)21(31-32)23(33)29-12-14-5-7-16(8-6-14)37(3,34)35/h9,13-16H,4-8,10-12H2,1-3H3,(H,28,30)(H,29,33)/t14-,16- DVCJVSRGIHUABO-KOMQPUFPSA-N 491768 4-Chloro-5-(6-((3,3-difluorocyclobutyl)amino)-4-methoxypyridin-3-yl)-1-ethyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 52 Nuclear receptor ROR-gamma Human 160 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491768&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286300 447118476 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022344 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(cc1OC)N1CC(C1)C(F)(F)F InChI=1S/C24H31ClF3N5O4S/c1-4-33-22(17-11-29-19(9-18(17)37-2)32-12-15(13-32)24(26,27)28)20(25)21(31-33)23(34)30-10-14-5-7-16(8-6-14)38(3,35)36/h9,11,14-16H,4-8,10,12-13H2,1-3H3,(H,30,34)/t14-,16- AUFURUQIRKZEOF-KOMQPUFPSA-N 491769 4-Chloro-1-ethyl-5-(4-methoxy-6-(3-(trifluoromethyl)azetidin-1-yl)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 53 Nuclear receptor ROR-gamma Human 450 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491769&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286305 447118477 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022345 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(cc1OC)N1CC(C1)OC(F)F InChI=1S/C24H32ClF2N5O5S/c1-4-32-22(17-11-28-19(9-18(17)36-2)31-12-15(13-31)37-24(26)27)20(25)21(30-32)23(33)29-10-14-5-7-16(8-6-14)38(3,34)35/h9,11,14-16,24H,4-8,10,12-13H2,1-3H3,(H,29,33)/t14-,16- QSHBRROXHAJEAX-KOMQPUFPSA-N 491770 4-Chloro-5-(6-(3-(difluoromethoxy)azetidin-1-yl)-4-methoxypyridin-3-yl)-1-ethyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 54 Nuclear receptor ROR-gamma Human 8600 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491770&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286267 447118478 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022346 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@H]2CCC(F)(F)C2)cc1OC InChI=1S/C25H34ClF2N5O4S/c1-4-33-23(18-14-29-20(11-19(18)37-2)31-16-9-10-25(27,28)12-16)21(26)22(32-33)24(34)30-13-15-5-7-17(8-6-15)38(3,35)36/h11,14-17H,4-10,12-13H2,1-3H3,(H,29,31)(H,30,34)/t15-,16-,17-/m0/s1 KYOZCBNEBCSIKF-ULQDDVLXSA-N 491771 4-Chloro-5-(6-(((S*)-3,3-difluorocyclopentyl)amino)-4-methoxypyridin-3-yl)-1-ethyl-N-(((1r,4S)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 55 Nuclear receptor ROR-gamma Human 110 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491771&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 156231179 447118479 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022347 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@@H]2CCC(F)(F)C2)cc1OC InChI=1S/C25H34ClF2N5O4S/c1-4-33-23(18-14-29-20(11-19(18)37-2)31-16-9-10-25(27,28)12-16)21(26)22(32-33)24(34)30-13-15-5-7-17(8-6-15)38(3,35)36/h11,14-17H,4-10,12-13H2,1-3H3,(H,29,31)(H,30,34)/t15-,16-,17-/m1/s1 KYOZCBNEBCSIKF-BRWVUGGUSA-N 491772 4-Chloro-5-(6-(((R*)-3,3-difluorocyclopentyl)amino)-4-methoxypyridin-3-yl)-1-ethyl-N-(((1r,4R)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 56 Nuclear receptor ROR-gamma Human 180 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491772&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286269 447118480 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022348 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@H]2CCCC2(F)F)cc1OC InChI=1S/C25H34ClF2N5O4S/c1-4-33-23(17-14-29-20(12-18(17)37-2)31-19-6-5-11-25(19,27)28)21(26)22(32-33)24(34)30-13-15-7-9-16(10-8-15)38(3,35)36/h12,14-16,19H,4-11,13H2,1-3H3,(H,29,31)(H,30,34)/t15-,16-,19-/m0/s1 OIKXQPGMLORAAQ-BXWFABGCSA-N 491773 4-Chloro-5-(6-(((S*)-2,2-difluorocyclopentyl)amino)-4-methoxypyridin-3-yl)-1-ethyl-N-(((1r,4S)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 57 Nuclear receptor ROR-gamma Human 32.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491773&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 156231199 447118481 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022349 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@@H]2CCCC2(F)F)cc1OC InChI=1S/C25H34ClF2N5O4S/c1-4-33-23(17-14-29-20(12-18(17)37-2)31-19-6-5-11-25(19,27)28)21(26)22(32-33)24(34)30-13-15-7-9-16(10-8-15)38(3,35)36/h12,14-16,19H,4-11,13H2,1-3H3,(H,29,31)(H,30,34)/t15-,16-,19-/m1/s1 OIKXQPGMLORAAQ-GPMSIDNRSA-N 491774 4-Chloro-5-(6-(((R*)-2,2-difluorocyclopentyl)amino)-4-methoxypyridin-3-yl)-1-ethyl-N-(((1r,4R)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 58 Nuclear receptor ROR-gamma Human 86.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491774&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286340 447118482 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022350 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2CCCCC2C(F)(F)F)cc1OC InChI=1S/C27H37ClF3N5O4S/c1-4-36-25(23(28)24(35-36)26(37)33-14-16-9-11-17(12-10-16)41(3,38)39)18-15-32-22(13-21(18)40-2)34-20-8-6-5-7-19(20)27(29,30)31/h13,15-17,19-20H,4-12,14H2,1-3H3,(H,32,34)(H,33,37)/t16-,17-,19?,20? YEZCQNSDHSDURP-IUALRMIASA-N 491775 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclohexyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction A::US10975057, Example 59 Nuclear receptor ROR-gamma Human 11.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491775&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286349 447118483 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022351 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2CCCCC2C(F)(F)F)cc1OC InChI=1S/C27H37ClF3N5O4S/c1-4-36-25(23(28)24(35-36)26(37)33-14-16-9-11-17(12-10-16)41(3,38)39)18-15-32-22(13-21(18)40-2)34-20-8-6-5-7-19(20)27(29,30)31/h13,15-17,19-20H,4-12,14H2,1-3H3,(H,32,34)(H,33,37)/t16-,17-,19?,20? YEZCQNSDHSDURP-IUALRMIASA-N 491776 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclohexyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction B::US10975057, Example 60 Nuclear receptor ROR-gamma Human 10.00 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491776&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286349 447118484 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022352 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2CCCC(C2)C(F)(F)F)cc1OC InChI=1S/C27H37ClF3N5O4S/c1-4-36-25(23(28)24(35-36)26(37)33-14-16-8-10-19(11-9-16)41(3,38)39)20-15-32-22(13-21(20)40-2)34-18-7-5-6-17(12-18)27(29,30)31/h13,15-19H,4-12,14H2,1-3H3,(H,32,34)(H,33,37)/t16-,17?,18?,19- GEPQZBVGHJXLEM-HFNQLMIASA-N 491777 4-Chloro-1-ethyl-5-(4-methoxy-6-((3-(trifluoromethyl)cyclohexyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction A::US10975057, Example 61 Nuclear receptor ROR-gamma Human 22.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491777&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286274 447118485 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022353 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2CCCC(C2)C(F)(F)F)cc1OC InChI=1S/C27H37ClF3N5O4S/c1-4-36-25(23(28)24(35-36)26(37)33-14-16-8-10-19(11-9-16)41(3,38)39)20-15-32-22(13-21(20)40-2)34-18-7-5-6-17(12-18)27(29,30)31/h13,15-19H,4-12,14H2,1-3H3,(H,32,34)(H,33,37)/t16-,17?,18?,19- GEPQZBVGHJXLEM-HFNQLMIASA-N 491778 4-Chloro-1-ethyl-5-(4-methoxy-6-((3-(trifluoromethyl)cyclohexyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction B::US10975057, Example 62 Nuclear receptor ROR-gamma Human 620 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491778&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286274 447118486 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022354 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2CCC(CC2)C(F)(F)F)cc1OC InChI=1S/C27H37ClF3N5O4S/c1-4-36-25(23(28)24(35-36)26(37)33-14-16-5-11-19(12-6-16)41(3,38)39)20-15-32-22(13-21(20)40-2)34-18-9-7-17(8-10-18)27(29,30)31/h13,15-19H,4-12,14H2,1-3H3,(H,32,34)(H,33,37)/t16-,17?,18?,19- FANRTUIFDIDUMR-HFNQLMIASA-N 491779 4-Chloro-1-ethyl-5-(4-methoxy-6-((4-(trifluoromethyl)cyclohexyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 63 Nuclear receptor ROR-gamma Human 2500 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491779&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286278 447118487 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022355 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2CC3(C2)CC(F)(F)C3)cc1OC InChI=1S/C27H36ClF2N5O4S/c1-4-35-24(22(28)23(34-35)25(36)32-12-16-5-7-18(8-6-16)40(3,37)38)19-13-31-21(9-20(19)39-2)33-17-10-26(11-17)14-27(29,30)15-26/h9,13,16-18H,4-8,10-12,14-15H2,1-3H3,(H,31,33)(H,32,36)/t16-,18- BEBSTMJTLYPZDK-SAABIXHNSA-N 491780 4-Chloro-5-(6-((6,6-difluorospiro[3.3]heptan-2-yl)amino)-4-methoxypyridin-3-yl)-1-ethyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 65 Nuclear receptor ROR-gamma Human 950 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491780&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286409 447118488 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022356 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCC2(CC2)C(F)(F)F)cc1OC InChI=1S/C25H33ClF3N5O4S/c1-4-34-22(17-13-30-19(11-18(17)38-2)32-14-24(9-10-24)25(27,28)29)20(26)21(33-34)23(35)31-12-15-5-7-16(8-6-15)39(3,36)37/h11,13,15-16H,4-10,12,14H2,1-3H3,(H,30,32)(H,31,35)/t15-,16- CZMHKWVCYUOXMX-WKILWMFISA-N 491781 4-Chloro-1-ethyl-5-(4-methoxy-6-(((1-(trifluoromethyl)cyclopropyl)methyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 66 Nuclear receptor ROR-gamma Human 11.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491781&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286276 447118489 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022357 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2(CC(F)(F)F)CC2)cc1OC InChI=1S/C25H33ClF3N5O4S/c1-4-34-22(17-13-30-19(11-18(17)38-2)32-24(9-10-24)14-25(27,28)29)20(26)21(33-34)23(35)31-12-15-5-7-16(8-6-15)39(3,36)37/h11,13,15-16H,4-10,12,14H2,1-3H3,(H,30,32)(H,31,35)/t15-,16- XIBBSHKLKXYHOU-WKILWMFISA-N 491782 4-Chloro-1-ethyl-5-(4-methoxy-6-((1-(2,2,2-trifluoroethyl)cyclopropyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 67 Nuclear receptor ROR-gamma Human 61.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491782&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286404 447118490 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022358 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCC2(CCC2)C(F)(F)F)cc1OC InChI=1S/C26H35ClF3N5O4S/c1-4-35-23(18-14-31-20(12-19(18)39-2)33-15-25(10-5-11-25)26(28,29)30)21(27)22(34-35)24(36)32-13-16-6-8-17(9-7-16)40(3,37)38/h12,14,16-17H,4-11,13,15H2,1-3H3,(H,31,33)(H,32,36)/t16-,17- BLOGHCODSGXVHZ-QAQDUYKDSA-N 491783 4-Chloro-1-ethyl-5-(4-methoxy-6-(((1-(trifluoromethyl)cyclobutyl)methyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 68 Nuclear receptor ROR-gamma Human 2.20 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491783&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286323 447118491 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022359 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NCC(C)(C)C(F)(F)F)cc1OC InChI=1S/C25H35ClF3N5O4S/c1-6-34-22(17-13-30-19(11-18(17)38-4)32-14-24(2,3)25(27,28)29)20(26)21(33-34)23(35)31-12-15-7-9-16(10-8-15)39(5,36)37/h11,13,15-16H,6-10,12,14H2,1-5H3,(H,30,32)(H,31,35)/t15-,16- GNYMYGYJELMONJ-WKILWMFISA-N 491784 4-Chloro-1-ethyl-5-(4-methoxy-6-((3,3,3-trifluoro-2,2-dimethylpropyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 69 Nuclear receptor ROR-gamma Human 5.60 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491784&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286321 447118492 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022360 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2CCC2C(F)(F)F)cc1OC InChI=1S/C25H33ClF3N5O4S/c1-4-34-23(16-13-30-20(11-19(16)38-2)32-18-10-9-17(18)25(27,28)29)21(26)22(33-34)24(35)31-12-14-5-7-15(8-6-14)39(3,36)37/h11,13-15,17-18H,4-10,12H2,1-3H3,(H,30,32)(H,31,35)/t14-,15-,17?,18? YBNBAGWVEIUCMS-VZHARNJASA-N 491785 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclobutyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction A::US10975057, Example 71::US10975057, Example 72 Nuclear receptor ROR-gamma Human 24.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491785&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286324 447118493 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022361 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2CCC2C(F)(F)F)cc1OC InChI=1S/C25H33ClF3N5O4S/c1-4-34-23(16-13-30-20(11-19(16)38-2)32-18-10-9-17(18)25(27,28)29)21(26)22(33-34)24(35)31-12-14-5-7-15(8-6-14)39(3,36)37/h11,13-15,17-18H,4-10,12H2,1-3H3,(H,30,32)(H,31,35)/t14-,15-,17?,18? YBNBAGWVEIUCMS-VZHARNJASA-N 491785 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclobutyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction A::US10975057, Example 71::US10975057, Example 72 Nuclear receptor ROR-gamma Human 73.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491785&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286324 447118493 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022362 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2C[C@@H](C2)C(F)(F)F)cc1OC InChI=1S/C25H33ClF3N5O4S/c1-4-34-23(18-13-30-20(11-19(18)38-2)32-16-9-15(10-16)25(27,28)29)21(26)22(33-34)24(35)31-12-14-5-7-17(8-6-14)39(3,36)37/h11,13-17H,4-10,12H2,1-3H3,(H,30,32)(H,31,35)/t14-,15-,16?,17- VMGIAQBSNJUFBA-KIAZBTLXSA-N 491787 4-Chloro-1-ethyl-5-(4-methoxy-6-(((1s*,3s*)-3-(trifluoromethyl)cyclobutyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 74 Nuclear receptor ROR-gamma Human 19000 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491787&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286262 447118494 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022363 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2C[C@@H](C2)C(F)(F)F)cc1OC InChI=1S/C25H33ClF3N5O4S/c1-4-34-23(18-13-30-20(11-19(18)38-2)32-16-9-15(10-16)25(27,28)29)21(26)22(33-34)24(35)31-12-14-5-7-17(8-6-14)39(3,36)37/h11,13-17H,4-10,12H2,1-3H3,(H,30,32)(H,31,35)/t14-,15-,16?,17- VMGIAQBSNJUFBA-KIAZBTLXSA-N 491788 4-Chloro-1-ethyl-5-(4-methoxy-6-(((1r*,3r*)-3-(trifluoromethyl)cyclobutyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 75 Nuclear receptor ROR-gamma Human 390 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491788&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286262 447118495 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022364 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2CC2C(F)(F)F)cc1OC InChI=1S/C24H31ClF3N5O4S/c1-4-33-22(15-12-29-19(10-18(15)37-2)31-17-9-16(17)24(26,27)28)20(25)21(32-33)23(34)30-11-13-5-7-14(8-6-13)38(3,35)36/h10,12-14,16-17H,4-9,11H2,1-3H3,(H,29,31)(H,30,34)/t13-,14-,16?,17? QZCJGSJPVBCGFU-RBAWDMFTSA-N 491789 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclopropyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction A::US10975057, Example 77 Nuclear receptor ROR-gamma Human 420 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491789&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286244 447118496 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022365 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2CC2C(F)(F)F)cc1OC InChI=1S/C24H31ClF3N5O4S/c1-4-33-22(15-12-29-19(10-18(15)37-2)31-17-9-16(17)24(26,27)28)20(25)21(32-33)23(34)30-11-13-5-7-14(8-6-13)38(3,35)36/h10,12-14,16-17H,4-9,11H2,1-3H3,(H,29,31)(H,30,34)/t13-,14-,16?,17? QZCJGSJPVBCGFU-RBAWDMFTSA-N 491790 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclopropyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction B::US10975057, Example 78 Nuclear receptor ROR-gamma Human 1200 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491790&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286244 447118497 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022366 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1OC InChI=1S/C25H35ClF3N5O5S/c1-6-34-21(16-12-30-18(11-17(16)39-4)32-23(2,3)13-25(27,28)29)19(26)20(33-34)22(35)31-14-24(36)9-7-15(8-10-24)40(5,37)38/h11-12,15,36H,6-10,13-14H2,1-5H3,(H,30,32)(H,31,35)/t15-,24+ YEUOHJIZSSQRAC-RWXRFDSASA-N 491791 4-Chloro-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-5-(4-methoxy-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1H-pyrazole-3-carboxamide::US10975057, Example 79 Nuclear receptor ROR-gamma Human 2.60 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491791&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286260 447118498 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022367 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1C InChI=1S/C25H35ClF3N5O4S/c1-6-34-21(17-12-30-18(11-15(17)2)32-23(3,4)13-25(27,28)29)19(26)20(33-34)22(35)31-14-24(36)9-7-16(8-10-24)39(5,37)38/h11-12,16,36H,6-10,13-14H2,1-5H3,(H,30,32)(H,31,35)/t16-,24+ RSSGABWZPFPKCZ-ONEIWYMKSA-N 491792 4-Chloro-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-5-(4-methyl-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1H-pyrazole-3-carboxamide::US10975057, Example 80 Nuclear receptor ROR-gamma Human 3.70 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491792&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286265 447118499 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022368 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC2(CC(F)(F)F)CC2)cc1C InChI=1S/C25H33ClF3N5O4S/c1-4-34-21(17-12-30-18(11-15(17)2)32-23(9-10-23)13-25(27,28)29)19(26)20(33-34)22(35)31-14-24(36)7-5-16(6-8-24)39(3,37)38/h11-12,16,36H,4-10,13-14H2,1-3H3,(H,30,32)(H,31,35)/t16-,24+ NYICXANBHBXGNS-ONEIWYMKSA-N 491793 4-Chloro-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-5-(4-methyl-6-((1-(2,2,2-trifluoroethyl)cyclopropyl)amino)pyridin-3-yl)-1H-pyrazole-3-carboxamide::US10975057, Example 81 Nuclear receptor ROR-gamma Human 190 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491793&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286261 447118500 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022369 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1C(F)(F)F InChI=1S/C25H32ClF6N5O4S/c1-5-37-20(15-11-33-17(10-16(15)25(30,31)32)35-22(2,3)12-24(27,28)29)18(26)19(36-37)21(38)34-13-23(39)8-6-14(7-9-23)42(4,40)41/h10-11,14,39H,5-9,12-13H2,1-4H3,(H,33,35)(H,34,38)/t14-,23+ AYMJYUZTPDYROE-GPCKLQJOSA-N 491794 4-Chloro-1-ethyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-5-(6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)-4-(trifluoromethyl)pyridin-3-yl)-1H-pyrazole-3-carboxamide::US10975057, Example 82::US10975057, Example 83 Nuclear receptor ROR-gamma Human 0.150 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491794&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286264 447118501 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022370 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1C(F)(F)F InChI=1S/C25H32ClF6N5O4S/c1-5-37-20(15-11-33-17(10-16(15)25(30,31)32)35-22(2,3)12-24(27,28)29)18(26)19(36-37)21(38)34-13-23(39)8-6-14(7-9-23)42(4,40)41/h10-11,14,39H,5-9,12-13H2,1-4H3,(H,33,35)(H,34,38)/t14-,23+ AYMJYUZTPDYROE-GPCKLQJOSA-N 491794 4-Chloro-1-ethyl-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-5-(6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)-4-(trifluoromethyl)pyridin-3-yl)-1H-pyrazole-3-carboxamide::US10975057, Example 82::US10975057, Example 83 Nuclear receptor ROR-gamma Human 0.400 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491794&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286264 447118501 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022371 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)CC(F)(F)F)cc1OC(F)F InChI=1S/C24H31ClF5N5O5S/c1-4-35-20(15-11-31-17(9-16(15)40-22(26)27)33-13(2)10-24(28,29)30)18(25)19(34-35)21(36)32-12-23(37)7-5-14(6-8-23)41(3,38)39/h9,11,13-14,22,37H,4-8,10,12H2,1-3H3,(H,31,33)(H,32,36)/t13?,14-,23+ XTIULIRUTPRFKK-GSXGDYRKSA-N 491796 4-Chloro-5-(4-(difluoromethoxy)-6-((4,4,4-trifluorobutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 84 Nuclear receptor ROR-gamma Human 54.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491796&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286312 447118502 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022372 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@@H](C)CC(F)(F)F)cc1OC(F)F InChI=1S/C24H31ClF5N5O5S/c1-4-35-20(15-11-31-17(9-16(15)40-22(26)27)33-13(2)10-24(28,29)30)18(25)19(34-35)21(36)32-12-23(37)7-5-14(6-8-23)41(3,38)39/h9,11,13-14,22,37H,4-8,10,12H2,1-3H3,(H,31,33)(H,32,36)/t13-,14-,23+/m0/s1 XTIULIRUTPRFKK-ZDODERHWSA-N 491797 4-Chloro-5-(4-(difluoromethoxy)-6-(((S*)-4,4,4-trifluorobutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4R)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 85 Nuclear receptor ROR-gamma Human 39.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491797&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286306 447118503 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022373 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@H](C)CC(F)(F)F)cc1OC(F)F InChI=1S/C24H31ClF5N5O5S/c1-4-35-20(15-11-31-17(9-16(15)40-22(26)27)33-13(2)10-24(28,29)30)18(25)19(34-35)21(36)32-12-23(37)7-5-14(6-8-23)41(3,38)39/h9,11,13-14,22,37H,4-8,10,12H2,1-3H3,(H,31,33)(H,32,36)/t13-,14-,23+/m1/s1 XTIULIRUTPRFKK-CSTKLKAISA-N 491798 4-Chloro-5-(4-(difluoromethoxy)-6-(((R*)-4,4,4-trifluorobutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4S)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 86 Nuclear receptor ROR-gamma Human 150 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491798&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286309 447118504 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022374 CCC(CC(F)(F)F)Nc1cc(OC(F)F)c(cn1)-c1c(Cl)c(nn1CC)C(=O)NC[C@@]1(O)CC[C@@H](CC1)S(C)(=O)=O InChI=1S/C25H33ClF5N5O5S/c1-4-14(11-25(29,30)31)34-18-10-17(41-23(27)28)16(12-32-18)21-19(26)20(35-36(21)5-2)22(37)33-13-24(38)8-6-15(7-9-24)42(3,39)40/h10,12,14-15,23,38H,4-9,11,13H2,1-3H3,(H,32,34)(H,33,37)/t14?,15-,24+ DDBCZGXUUVTEKV-WAOZNNHRSA-N 491799 4-Chloro-5-(4-(difluoromethoxy)-6-((1,1,1-trifluoropentan-3-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 87 Nuclear receptor ROR-gamma Human 44.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491799&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286307 447118505 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022375 CC[C@@H](CC(F)(F)F)Nc1cc(OC(F)F)c(cn1)-c1c(Cl)c(nn1CC)C(=O)NC[C@@]1(O)CC[C@@H](CC1)S(C)(=O)=O InChI=1S/C25H33ClF5N5O5S/c1-4-14(11-25(29,30)31)34-18-10-17(41-23(27)28)16(12-32-18)21-19(26)20(35-36(21)5-2)22(37)33-13-24(38)8-6-15(7-9-24)42(3,39)40/h10,12,14-15,23,38H,4-9,11,13H2,1-3H3,(H,32,34)(H,33,37)/t14-,15-,24+/m0/s1 DDBCZGXUUVTEKV-ZEUIUJOJSA-N 491800 4-Chloro-5-(4-(difluoromethoxy)-6-(((S*)-1,1,1-trifluoropentan-3-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4R)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 88 Nuclear receptor ROR-gamma Human 61.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491800&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286308 447118506 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022376 CC[C@H](CC(F)(F)F)Nc1cc(OC(F)F)c(cn1)-c1c(Cl)c(nn1CC)C(=O)NC[C@@]1(O)CC[C@@H](CC1)S(C)(=O)=O InChI=1S/C25H33ClF5N5O5S/c1-4-14(11-25(29,30)31)34-18-10-17(41-23(27)28)16(12-32-18)21-19(26)20(35-36(21)5-2)22(37)33-13-24(38)8-6-15(7-9-24)42(3,39)40/h10,12,14-15,23,38H,4-9,11,13H2,1-3H3,(H,32,34)(H,33,37)/t14-,15-,24+/m1/s1 DDBCZGXUUVTEKV-FENDNCTDSA-N 491801 4-Chloro-5-(4-(difluoromethoxy)-6-(((R*)-1,1,1-trifluoropentan-3-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4S)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 89 Nuclear receptor ROR-gamma Human 23.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491801&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286310 447118507 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022377 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(CC(F)(F)F)C2CC2)cc1OC(F)F InChI=1S/C26H33ClF5N5O5S/c1-3-37-22(20(27)21(36-37)23(38)34-13-25(39)8-6-15(7-9-25)43(2,40)41)16-12-33-19(10-18(16)42-24(28)29)35-17(14-4-5-14)11-26(30,31)32/h10,12,14-15,17,24,39H,3-9,11,13H2,1-2H3,(H,33,35)(H,34,38)/t15-,17?,25+ YFQQVWAGVQJMPN-LICVSKRTSA-N 491802 4-Chloro-5-(6-((1-cyclopropyl-3,3,3-trifluoropropyl)amino)-4-(difluoromethoxy)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 90 Nuclear receptor ROR-gamma Human 24.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491802&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286304 447118508 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022378 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@@H](CC(F)(F)F)C2CC2)cc1OC(F)F InChI=1S/C26H33ClF5N5O5S/c1-3-37-22(20(27)21(36-37)23(38)34-13-25(39)8-6-15(7-9-25)43(2,40)41)16-12-33-19(10-18(16)42-24(28)29)35-17(14-4-5-14)11-26(30,31)32/h10,12,14-15,17,24,39H,3-9,11,13H2,1-2H3,(H,33,35)(H,34,38)/t15-,17-,25+/m0/s1 YFQQVWAGVQJMPN-LMZHUWQESA-N 491803 4-Chloro-5-(6-(((S*)-1-cyclopropyl-3,3,3-trifluoropropyl)amino)-4-(difluoromethoxy)pyridin-3-yl)-1-ethyl-N-(((1s,4R)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 91 Nuclear receptor ROR-gamma Human 39.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491803&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286333 447118509 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022379 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@H](CC(F)(F)F)C2CC2)cc1OC(F)F InChI=1S/C26H33ClF5N5O5S/c1-3-37-22(20(27)21(36-37)23(38)34-13-25(39)8-6-15(7-9-25)43(2,40)41)16-12-33-19(10-18(16)42-24(28)29)35-17(14-4-5-14)11-26(30,31)32/h10,12,14-15,17,24,39H,3-9,11,13H2,1-2H3,(H,33,35)(H,34,38)/t15-,17-,25+/m1/s1 YFQQVWAGVQJMPN-HMFAJSFMSA-N 491804 4-Chloro-5-(6-(((R*)-1-cyclopropyl-3,3,3-trifluoropropyl)amino)-4-(difluoromethoxy)pyridin-3-yl)-1-ethyl-N-(((1s,4S)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 92 Nuclear receptor ROR-gamma Human 20.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491804&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286373 447118510 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022380 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)CC2CC2)cc1OC(F)F InChI=1S/C26H36ClF2N5O5S/c1-4-34-23(18-13-30-20(12-19(18)39-25(28)29)32-15(2)11-16-5-6-16)21(27)22(33-34)24(35)31-14-26(36)9-7-17(8-10-26)40(3,37)38/h12-13,15-17,25,36H,4-11,14H2,1-3H3,(H,30,32)(H,31,35)/t15?,17-,26+ GCBMREYTIIUNDR-QJCUHYLBSA-N 491805 4-Chloro-5-(6-((1-cyclopropylpropan-2-yl)amino)-4-(difluoromethoxy)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 93 Nuclear receptor ROR-gamma Human 37.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491805&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286240 447118511 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022381 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@@H](C)CC2CC2)cc1OC(F)F InChI=1S/C26H36ClF2N5O5S/c1-4-34-23(18-13-30-20(12-19(18)39-25(28)29)32-15(2)11-16-5-6-16)21(27)22(33-34)24(35)31-14-26(36)9-7-17(8-10-26)40(3,37)38/h12-13,15-17,25,36H,4-11,14H2,1-3H3,(H,30,32)(H,31,35)/t15-,17-,26+/m0/s1 GCBMREYTIIUNDR-RVLLUPRFSA-N 491806 4-Chloro-5-(6-(((S*)-1-cyclopropylpropan-2-yl)amino)-4-(difluoromethoxy)pyridin-3-yl)-1-ethyl-N-(((1s,4R)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 94 Nuclear receptor ROR-gamma Human 120 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491806&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286347 447118512 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022382 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@H](C)CC2CC2)cc1OC(F)F InChI=1S/C26H36ClF2N5O5S/c1-4-34-23(18-13-30-20(12-19(18)39-25(28)29)32-15(2)11-16-5-6-16)21(27)22(33-34)24(35)31-14-26(36)9-7-17(8-10-26)40(3,37)38/h12-13,15-17,25,36H,4-11,14H2,1-3H3,(H,30,32)(H,31,35)/t15-,17-,26+/m1/s1 GCBMREYTIIUNDR-MBXZGBHRSA-N 491807 4-Chloro-5-(6-(((R*)-1-cyclopropylpropan-2-yl)amino)-4-(difluoromethoxy)pyridin-3-yl)-1-ethyl-N-(((1s,4S)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 95 Nuclear receptor ROR-gamma Human 23.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491807&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286282 447118513 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022383 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC2CC2)cc1OC(F)F InChI=1S/C27H38ClF2N5O5S/c1-5-35-23(18-14-31-20(12-19(18)40-25(29)30)33-26(2,3)13-16-6-7-16)21(28)22(34-35)24(36)32-15-27(37)10-8-17(9-11-27)41(4,38)39/h12,14,16-17,25,37H,5-11,13,15H2,1-4H3,(H,31,33)(H,32,36)/t17-,27+ JMRZBJCCHWZJEY-NZFXNERUSA-N 491808 4-Chloro-5-(6-((1-cyclopropyl-2-methylpropan-2-yl)amino)-4-(difluoromethoxy)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 96 Nuclear receptor ROR-gamma Human 1.50 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491808&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286311 447118514 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022384 CCn1nc(C(=O)NC[C@@]2(O)CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(NC(C)(C)CC(F)(F)F)cc1C(F)F InChI=1S/C25H33ClF5N5O4S/c1-5-36-20(16-11-32-17(10-15(16)21(27)28)34-23(2,3)12-25(29,30)31)18(26)19(35-36)22(37)33-13-24(38)8-6-14(7-9-24)41(4,39)40/h10-11,14,21,38H,5-9,12-13H2,1-4H3,(H,32,34)(H,33,37)/t14-,24+ LTAKCRBOEKEZOP-XCNUYCIISA-N 491809 4-Chloro-5-(4-(difluoromethyl)-6-((4,4,4-trifluoro-2-methylbutan-2-yl)amino)pyridin-3-yl)-1-ethyl-N-(((1s,4s)-1-hydroxy-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 97 Nuclear receptor ROR-gamma Human 0.920 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491809&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 156231188 447118515 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 1022385 CCn1nc(C(=O)NC[C@H]2CC[C@@H](CC2)S(C)(=O)=O)c(Cl)c1-c1cnc(N[C@H](C)C(F)(F)F)cc1OC InChI=1S/C23H31ClF3N5O4S/c1-5-32-21(16-12-28-18(10-17(16)36-3)30-13(2)23(25,26)27)19(24)20(31-32)22(33)29-11-14-6-8-15(9-7-14)37(4,34)35/h10,12-15H,5-9,11H2,1-4H3,(H,28,30)(H,29,33)/t13-,14-,15-/m1/s1 FPRUJLLMMGTSLP-RBSFLKMASA-N 491810 4-Chloro-1-ethyl-5-(4-methoxy-6-(((R)-1,1,1-trifluoropropan-2-yl)amino)pyridin-3-yl)-N-(((1r,4R)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide::US10975057, Example 98 Nuclear receptor ROR-gamma Human 22.0 US Patent 10.7270/Q2QV3QMN aid1805439 US10975057 Goldberg, S; Martin, CL; Fennema, EG; Kummer, DA; Nishimura, RT; Fourie, AM; Xue, X 4/13/2021 10/20/2021 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=491810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=491810&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 146286360 447118516 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8